PRORP
Basic information
Region (hg38): 14:35121846-35277622
Previous symbols: [ "KIAA0391" ]
Links
Phenotypes
GenCC
Source:
- combined oxidative phosphorylation deficiency 54 (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Combined oxidative phosphorylation deficiency 54 | AR | Audiologic/Otolaryngologic | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development | Audiologic/Otolaryngologic; Biochemical; Endocrine; Neurologic; Obstetric | 34715011 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (62 variants)
- Combined_oxidative_phosphorylation_deficiency_54 (12 variants)
- not_provided (5 variants)
- PRORP-related_disorder (4 variants)
- Childhood_onset_sensorineural_hearing_impairment (4 variants)
- Leukoencephalopathy (3 variants)
- Hypertonia (2 variants)
- Lactic_acidosis (2 variants)
- Global_developmental_delay (2 variants)
- Microcephaly (2 variants)
- Persistent_lactic_acidosis (2 variants)
- Feeding_difficulties (2 variants)
- Perrault_syndrome_1 (2 variants)
- Diffuse_white_matter_abnormalities (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRORP gene is commonly pathogenic or not. These statistics are base on transcript: NM_000014672.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | |||||
| missense | 55 | 10 | 68 | |||
| nonsense | 1 | |||||
| start loss | 0 | |||||
| frameshift | 3 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 4 | 58 | 14 | 0 |
Highest pathogenic variant AF is 0.00006016922
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PRORP | protein_coding | protein_coding | ENST00000534898 | 7 | 152220 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.33e-13 | 0.0902 | 125698 | 0 | 49 | 125747 | 0.000195 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.777 | 270 | 308 | 0.875 | 0.0000157 | 3843 |
| Missense in Polyphen | 155 | 189.56 | 0.81768 | 2519 | ||
| Synonymous | 0.793 | 101 | 112 | 0.905 | 0.00000544 | 1099 |
| Loss of Function | 0.678 | 22 | 25.7 | 0.856 | 0.00000125 | 324 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000235 | 0.000235 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000219 | 0.000217 |
| Finnish | 0.0000463 | 0.0000462 |
| European (Non-Finnish) | 0.000278 | 0.000273 |
| Middle Eastern | 0.000219 | 0.000217 |
| South Asian | 0.000131 | 0.000131 |
| Other | 0.000331 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Catalytic ribonuclease component of mitochondrial ribonuclease P, a complex composed of TRMT10C/MRPP1, HSD17B10/MRPP2 and MRPP3, which cleaves tRNA molecules in their 5'-ends (PubMed:18984158, PubMed:25953853). The presence of TRMT10C/MRPP1, HSD17B10/MRPP2 is required to catalyze tRNA molecules in their 5'-ends (PubMed:25953853). {ECO:0000269|PubMed:18984158, ECO:0000269|PubMed:25953853}.;
- Pathway
- tRNA processing;tRNA modification in the mitochondrion;Metabolism of RNA
(Consensus)
Recessive Scores
- pRec
- 0.0833
Intolerance Scores
- loftool
- 0.927
- rvis_EVS
- 0.15
- rvis_percentile_EVS
- 64.74
Haploinsufficiency Scores
- pHI
- 0.0313
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.385
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.726
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- 1110008L16Rik
- Phenotype
Gene ontology
- Biological process
- tRNA 5'-leader removal;RNA phosphodiester bond hydrolysis, endonucleolytic;mitochondrial tRNA processing;mitochondrial tRNA 5'-end processing
- Cellular component
- nucleus;mitochondrion;mitochondrial matrix;mitochondrial ribonuclease P complex;mitochondrial nucleoid
- Molecular function
- ribonuclease P activity;metal ion binding